Registration is required to view this event live or on demand. Please complete the form or login below.
Determining the Impact of New Therapeutic Approaches: Advancing Imaging in Animals
Event Date: ; 9 a.m. PT; 5 p.m. GMT, 6 p.m. CEST
Sponsored by PerkinElmer
A major advantage of in vivo imaging by fluorescence tomography is that it enables the study of biological targets and pathways in context and in their natural state. Within a preclinical setting, such imaging allows disease states to be observed and measured non-invasively within the whole animal, bridging the gap between drug discovery and human clinical trials. Specifically, the Imaging agents developed in the laboratory for use in fluorescence molecular tomography, are now even being translated into the clinic for human diagnostic applications. Similarly, disease-specific fluorescence markers are finding their way back into basic research in high content screening applications. In this third and final webinar in our cell to well to animal series, we will survey the in vivo imaging landscape and follow the flow of technologies and methodologies between lab and clinic.
During the webinar, our expert panelists will:
Discuss the most important considerations when performing in vivo imaging
Describe how in vivo imaging has been applied in their research
Provide examples of the impact new technologies are having on fundamental research and drug development
Answer your questions live!
If you have already registered for this webinar, you may sign in here.